Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Management of Steroid-Induced Hyperglycemia in Patients with Type 2 Diabetes

Introduction to Steroid-Induced Hyperglycemia

  • The American College of Endocrinology recommends starting NPH insulin at 0.3-0.5 units/kg/day given in the morning to match the afternoon peak hyperglycemic effect of glucocorticoids, with dose adjustments proportional to steroid tapering 1, 2
  • Peak hyperglycemia occurs 6-9 hours after morning steroid administration, typically in the afternoon and evening, with glucose levels often normalizing overnight even without treatment 1, 2

Understanding Hyperglycemic Patterns

  • The degree of hyperglycemia directly correlates with the steroid dose—higher doses cause more significant elevations 1, 3
  • Prednisolone causes hyperglycemia predominantly between midday and midnight, with peak effects approximately 8 hours after morning administration 3

Monitoring and Insulin Therapy

  • Implement four-times-daily glucose monitoring (fasting and 2 hours after each meal) rather than relying on fasting glucose alone, which will miss the peak hyperglycemic effect 1, 2, 3
  • Target glucose range: 5-10 mmol/L (90-180 mg/dL) 1, 2, 3
  • NPH insulin is the preferred agent because its 4-6 hour peak action aligns with the peak hyperglycemic effect of morning glucocorticoid doses 1, 2
  • Starting dose: 0.3-0.5 units/kg/day given in the morning (or 3 hours after steroid administration) 1, 2, 3

Dose Adjustment and Oral Antidiabetic Agents

  • As steroids are tapered, insulin doses must be proportionally decreased to prevent hypoglycemia 1, 2, 3
  • Adjust insulin based on blood glucose patterns, focusing on afternoon/evening readings 1, 2
  • Oral agents alone are insufficient for high-dose steroid therapy 1, 4
  • Continue metformin as an adjunct in patients with preserved renal and hepatic function, with some evidence it alleviates metabolic effects of steroids 1, 3

Critical Warning Signs and Patient Education

  • Hyperosmolar hyperglycemic state can develop in very severe cases 1, 2, 3
  • Warn patients that capillary blood glucose persistently above 20 mmol/L despite treatment, or glucose meter reading "HI," requires immediate hospital presentation 1, 3
  • Provide comprehensive education on glucose monitoring technique and frequency, symptoms of severe hyperglycemia and emergency thresholds, and when to seek medical attention 1, 3

Common Pitfalls to Avoid

  • Failing to anticipate the diurnal pattern of steroid-induced hyperglycemia, with peak effects in the afternoon and evening 1, 2
  • Using only fasting glucose to monitor steroid-induced hyperglycemia (will miss the peak hyperglycemic effect) 1, 2
  • Not reducing insulin doses when steroid doses are tapered, leading to hypoglycemia 1, 2
  • Relying solely on oral antidiabetic agents for high-dose steroid therapy 1, 4

REFERENCES

1

Management of Hyperglycemia Due to Chemotherapy and Steroids [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Steroid-Induced Diabetes [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Steroid-Induced Hyperglycemia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025